Many Investors Still Treating Gilead: 4 Launches This Year Could Prove Them Wrong
Gilead sits at a crossroads: the HIV backbone remains strong, but a quartet of new launches could reshape the company...
Price indices track market movements to gauge overall levels. This intro explains what a price index is and why it matters for investors and analysts.
21,879 articlesGilead sits at a crossroads: the HIV backbone remains strong, but a quartet of new launches could reshape the company...
IBM is quietly reshaping its story with a serious quantum strategy, strong enterprise demand, and a durable dividend....
Public disclosures show surprising activity in major names, but smart investing hinges on fundamentals, risk, and a d...
A pivotal move in AI investing just happened: a memory-focused chip stock joined Nasdaq, giving investors a new way t...
As Berkshire's new investment captain, Greg Abel faces a pivotal test: can his Q2 moves in Alphabet, Mitsubishi, Maru...
Long-term investors can grow wealth with dividend ETFs built long-term that blend reliable income with growth potenti...
Imagine a world where chair kevin warsh takes the helm of the Fed under a Trump political backdrop. This article brea...
Meta is shifting from a pure ads business to an AI-driven platform layer. This article breaks down Meta's moves aroun...
Arm Holdings has rocketed 144% year-to-date, led by data center royalties and its first production silicon. Analysts ...
PulteGroup accelerates its shift toward build-to-order homes to support margins as the 2026 housing market stays vola...
A fresh Council of Economic Advisers report challenges the net cost figures tied to CFPB rules, arguing higher rates ...
Traders are chasing the best stocks trade opportunities in a volatile February session. The focus is on highly liquid...